|
[1] SHEN F,ZHANG H,YANG T,et al. The comprehensive surgical management for intrahepatic cholangiocarcinoma[J].Chin J Dig Surg,2018,17(3):213-218.(in Chinese)沈锋，张汉，杨田，等．肝内胆管癌的外科综合治疗[J]．中华消化外科杂志，2018,17(3):213-218.
|
|
[2] ZHANG K,CHE S,PAN C,et al. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway[J]. J Cell Mol Med,2018,22(7):3679-3690.
|
|
[3] YANG J,CAO Y,JIANG Y,et al. Relationship between expression of CD44,CD90 and prognosis of liver transplantation for hepatocellular carcinoma[J]. Mod Oncol,2017,25(19):3089-3094.(in Chinese)杨杰，曹毅，江艺，等．CD44,CD90的表达与肝癌肝移植术后复发转移的关系[J]．现代肿瘤医学，2017,25(19):3089-3094.
|
|
[4] DONG W,LIU L,CHEN Y,et al. The expressions and clinical significance of Ezrin and PTEN protein in intrahepatic cholangiocarcinoma[J]. Chin J Hepatobiliary Surg,2018,24(8):537-541.(in Chinese)董伟，刘路，陈赢，等．肝内胆管细胞癌中Ezrin和PTEN蛋白的表达及其临床意义[J]．中华肝胆外科杂志，2018,24(8):537-541.
|
|
[5] SUN L,GUO C,BURNETT J,et al. Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development[J]. J Cancer,2017,8(1):111-116.
|
|
[6] TANG ZH,TANG CW,WANG SH,et al. The research situation and progress in the invasion and metastasis mechanism of intrahepatic cholangiocarcinoma[J]. Chin J Dig Surg,2019,18(4):321-327.(in Chinese)汤朝晖，唐陈伟，王寿华，等．肝内胆管癌侵袭转移机制的研究现状与进展[J]．中华消化外科杂志，2019,18(4):321-327.
|
|
[7] SONG ZC,GUO CL,TANG JH,et al. Effect of PRR11 on the prognosis of patients with intrahepatic cholangiocarcinoma[J]. Chin J Gastroenterol Hepatol,2018,27(4):409-412.(in Chinese)宋宗昌，郭春亮，唐家宏，等．PRR11对肝内胆管细胞癌患者预后的影响[J]．胃肠病学和肝病学杂志，2018,27(4):409-412.
|
|
[8] LIU Q,CHEN K,LIU Z,et al. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells[J]. Cancer Lett,2017,403:165-174.
|
|
[9] SHAO YM,ZHANG Y,YIN X,et al. Value of Sal-like 4 in the diagnosis and treatment of primary liver cancer[J]. J Clin Hepatol,2019,35(10):2320-2323.(in Chinese)邵玥明，张雨，殷鑫，等．SALL4在原发性肝癌诊治中的价值[J]．临床肝胆病杂志，2019,35(10):2320-2323.
|
|
[10] GAO SH,GAN HY,WANG J. Establishment of Nomogram model of postoperative recurrence of primary hepatocellular carcinoma with reference to inflammatory cytokines[J]. J Clin Hepatol,2019,35(7):1520-1524.(in Chinese)高素华，甘洪颖，王君．结合炎性细胞因子构建原发性肝癌术后复发的Nomogram模型[J]．临床肝胆病杂志，2019,35(7):1520-1524.
|
|
[11] TIAN YH,DU YC,HE YH,et al. The effect of CDCA5 on the prognosis and growth promoting in hepatocellular carcinoma[J]. Med J West China,2019,31(7):1014-1020.(in Chinese)田云鸿，杜毅超，何云洪，等．CDCA5对肝癌患者预后的影响及机制研究[J]．西部医学，2019,31(7):1014-1020.
|
|
[12] SU BW,BAI MH,LIU HC. Expression and significance of Fascin-1 in intrahepatic cholangiocarcinoma[J]. Guangdong Med J,2019,40(8):1091-1094.(in Chinese)苏宝威，白明辉，刘海潮．Fascin-1在肝内胆管细胞癌中的表达及意义[J]．广东医学，2019,40(8):1091-1094.
|
|
[13] LI J,HH SB,WANG LY,et al. Autophagy-dependent generation of Axin2+cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis[J]. Oncogene,2017,36(48):6725-6737.
|
|
[14] WANG C,WU H,LIU Y,et al. Expression features and prognostic significance of Yes-associated protein in hepatocellular carcinoma and cholangiocellular carcinoma[J]. J Clin Hepatol,2017,33(7):1310-1315.(in Chinese)王春，邬昊，刘彦，等．Yes相关蛋白在肝细胞癌与胆管细胞癌中的表达特征及其与预后的关系[J]．临床肝胆病杂志，2017,33(7):1310-1315.
|
|
[15] YE HY,XU JW,CHEN L,et al. Expression and clinical significance of hsa-miRNA-200c in patients with liver metastasis of epithelial ovarian cancer[J]. Chin J Pract Gynecol Obstetr,2019,35(5):574-578.(in Chinese)叶海燕，徐嘉文，陈乐，等．hsa-miRNA-200c在肝转移型卵巢上皮性癌中的表达及其临床意义[J]．中国实用妇科与产科杂志，2019,35(5):574-578.
|
|
[16] LIU XY,HE YY,PENG C,et al. Mucin-3 and-4 expressions in hepatolithiasis-associated intrahepatic cholangiocarcinoma and their significance[J]. Chin J Gen Surg,2018,27(2):193-198.(in Chinese)刘鑫宇，贺彦宇，彭创，等．黏蛋白3和黏蛋白4在结石相关肝内胆管细胞癌中的表达及意义[J]．中国普通外科杂志，2018,27(2):193-198.
|
|
[17] ZHAO LF,CHENG WH,LEI D,et al. The relationship between DKK1 protein expression and lymph node invasion,and prognosis in patients with intrahepatic cholangiocarcinoma[J].Pract Oncol J,2017,31(3):228-233.(in Chinese)赵利锋，程伟华，雷达，等．DKK1蛋白表达与肝内胆管细胞癌患者淋巴结侵犯及其预后的相关性研究[J]．实用肿瘤学杂志，2017,31(3):228-233.
|
|
[18] ZHANG K,CHE S,SU Z,et al. CD90 promotes cell migration,viability and sphere-forming ability of hepatocellular carcinoma cells[J]. Int J Mol Med,2018,41(2):946-954.
|
|
[19] PENG R,HUANG XY,CAI JB,et al. Expression and clinical significance of TRIM44 and MMP9 in intrahepatic cholangiocarcinoma[J]. Chin J Clinl Med,2018,25(4):573-577.(in Chinese)彭睿，黄晓勇，蔡加彬，等．肝内胆管癌TRIM44、基质金属蛋白酶9蛋白的表达及临床意义[J]．中国临床医学，2018,25(4):573-577.
|
|
[20] YANG HY,LIU Y,DAI YZ,et al. Expression of CD90 and its clinical significance in different molecular subtypes of breast invasive ductal carcinoma[J]. Chin J Clin Exp Pathol,2017,33(3):245-249.(in Chinese)杨海玉，刘勇，戴艳枝，等．乳腺浸润性导管癌不同分子分型中CD90的表达及其意义[J]．临床与实验病理学杂志，2017,33(3):245-249.
|
|
[21] KANG Q,ZOU H,LIU LX,et al. Snail expression in intrahepatic cholangiocarcinoma and its clinical significance[J].Chin J Gen Surg,2017,26(2):199-204.(in Chinese)康强，邹浩，刘立鑫，等．Snail在肝内胆管癌中的表达及其临床意义[J]．中国普通外科杂志，2017,26(2):199-204.
|
DownLoad: